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In their review Li et al. [1] focused on bacteria and particularly on 
Helicobacter pylori infection (Hp-I) involvement in pancreatic cancer 
pathophysiology by many molecular potential mechanisms. 
Hp is the fundamental cause of gastric ulcer disease also associated 
with autoimmune pancreatitis (AIP) [2] and as a class I carcinogen may also 
be implicated, through molecular mimicry, in the pathophysiology of AIP and 
probably of pancreatic malignancy; this pathogen appears to be involved in 
AIP via induction of autoimmunity and apoptosis [3], and, apart from other 
molecular mechanisms some of which also mentioned by the authors [1,4] 
Hp-I may also contribute to pancreatic carcinogenesis by altered apoptotic 
pathways [4,5].
Specifically, relative data [6] identified that: a) peptide AIP1-7 showed 
homology with Hp plasminogen-binding protein (PBP) and with the enzyme 
biquitin-protein ligase E3 component n-recognin 2, expressed in pancreatic 
acinar cells; and b) the antibody against PBP was associated with AIP. Hp 
was found to bind plasminogen by Hp PBPs, enhancing its virulence [7]. 
These data appear to support our proposition [3,8] that Hp might trigger AIP 
through molecular mimicry and its increased virulence. Plasminogen binding 
and its conversion to plasmin is the only proteolytic activity of Hp, it may 
enhance tissue damage [7] and is involved in carcinogenesis; anti–PBP 
peptide antibody is present in patients with pancreatic cancer [6]. Besides, 
Guarneri et al. [9] found homology between human pancreatic autoantigen 
carbonic anhydrase II and α-carbonic anhydrase of Hp, a fundamental 































































enzyme for Hp survival and proliferation; the homologous segments contained 
the binding motif of the HLA molecule DRB1*0405 [9]. These data further 
strengthen our assumption that Hp infection can trigger AIP in genetically 
predisposed subjects and consequence pancreatic cancer. 
In this regard several studies have proposed that the risk of pancreatic 
malignancy is high in patients with AIP [10]; IgG4-related disease is 
associated with cancer development especially during the first year after 
diagnosis, thereby signifying that active IgG4-related disease appears to be a 
strong risk factor for cancer development [11]; Hp a-carbonic anhydrase  
inhibitors may be introduced  in the management of gastric ulcers and cancer 
[12]; pancreatic CAII-expressing cells give rise to new islet and acinar cells 
following birth and injury which may arise pancreatic malignancy from the 
uncontrolled growth of progenitor/stem cells [13]; bone marrow-derived stem 
cells (BMDSCs) are involved in the development and/or progression 
of pancreatic cancer [14]; and Hp-I by recruiting BMDSCs  may facilitate 
cancer development and progression in animal models and humans [15,16]. 
Therefore, Hp eradication may also positive influence AIP patients by 
ameliorating the autoimmune sequelae and subsequent development of 
pancreatic cancer, and thus further studies are needed.
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